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. Its onset can occur during childhood or adolescence, in an average of 12 years (7 months -59 years), but there was not one in adults in Brazil, with neurological signs such as cognitive decline, seizures and pyramidal, extrapyramidal or cerebellar signs 1, 2 . Our patient, unlike the other cases reported in literature, presented its first neurological manifestation at the age of 24. CT and MRI seen in our case were similar to the cases reported in literature, showing increased signal intensity of the white matter on MRI (T2 and FLAIR), basal ganglia calcification, and development of cysts [1] [2] [3] . Labrune reported the results of histopathology with rearrangement involving the microvessels, whereas perivascular foci of calcifications, hyaline deposits, and formation of Rosenthal fibers seem to be compatible with this change 1 . The histopathological findings of our patient were consistent with LCC. According to them, the likely primary pathologic feature is a rearrangement involving the microvessels and the formation of Rosenthal fibers 1, 4 .
In conclusion, the etiology of LCC remains unknown. In spite of relatively characteristic findings in imaging and histopathological examination, there is no uniformity in the clinical findings noted in the published articles. It can be speculated that the later age of onset, normal intelligence and slow progression, like in our patient, may indicate the shape of this rare disease in adults.
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Metamorphopsia associated with topiramate for migraine prevention
Metamorfopsia associada ao uso de topiramato para prevenção de enxaqueca A 33-year-old woman (registration 70-247/ IPUB-UFRJ) has had recurring headaches since the age of 18. She described more right-sided than left-sided throbbing, which could be severe and associated with nausea, light and noise sensitivity, and vomiting. She has had a visual aura, seeing "zig-zags", lasting for 20 to 30 minutes before the headaches. The only preventive measure she had taken in the past was divalproex sodium, with good efficacy. Because of the weight gain as a side effect, she refused to take it again. Her body mass index (BMI) was 35.3. She was started on preventive therapy with topiramate at 25 mg daily for two weeks that was to be increased weekly to 100 mg daily. After 13 days of treatment, she developed continuous visual illusions upon waking in the morning; when looking at human faces, they were distorted and swollen. On many occasions, objects in front of her appeared to be either nearer or farther away. These visual phenomena persisted for approximately 12 hours and gradually disappeared with the discontinuation of topiramate. Thereafter, she never had similar experiences. None of these events was accompanied by the loss of consciousness or headache. The patient's impressions of reality and self-recognition were preserved. The neurological and psychiatric examination was normal, and a complete examination by a neuro-ophthalmologist was normal. An EEG, with activation procedures (hyperventilation and photic stimulation), and the MRI of the brain were normal.
Metamorphopsia is a visual illusion affecting the perception of the size, shape or inclination of objects 1 . Although this condition occurs in migraine aura, topiramate has been reported to induce other visual illusions, such as palinopsia (the illusion of a persistent or recurrent visual images following the removal of the exciting stimulus) 2 and alterations in body perception ("Alice in Wonderland syndrome") in patients with migraines 3 .
The mechanism by which topiramate may cause these visual illusions in migraineurs is unknown. However, because it may occur in the aura of migraines, these visual illusions are likely to be a result of the migraine.
